Engineered cyclodextrin-protein domain interface modulation and application in nanoscale delivery systems development...

Area of Science:

• Biomaterials Science
• Pharmaceutical Sciences
• Nanotechnology

Background:

• Proteins are vital therapeutics but suffer from poor stability, rapid metabolism, and inefficient delivery.
• Biocompatible materials offer a strategy to overcome these limitations and enhance protein drug efficacy.
• Cyclodextrins (CDs) show promise for protein drug formulation due to their unique structure and properties.

Purpose of the Study:

• To review the physicochemical properties of Cyclodextrins (CDs) and their derivatives.
• To summarize the interactions between proteins and CD-based nanoplatforms.
• To explore the applications of CDs in improving protein drug stability, delivery, and biological signaling.

Main Methods:

• Literature review of physicochemical properties of CDs and their derivatives.
• Analysis of protein-CD interactions, including stability, corona formation, and drug delivery mechanisms.
• Discussion of CD applications in protein therapeutics and biological pathways.

Main Results:

• CDs can positively modulate protein drug stability and solubility.
• CD-based nanoplatforms facilitate effective protein drug delivery and cellular uptake.
• CDs demonstrate potential for direct involvement in biological signaling pathway regulation.

Conclusions:

• Cyclodextrins offer a versatile platform for overcoming challenges in protein-based drug development.
• Sophisticated design of CD-related systems can significantly enhance therapeutic outcomes.
• Further research into CD-protein interactions will drive innovation in protein drug delivery.